Jens Fischer
Jens Fischer, Schleiz DE
Patent application number | Description | Published |
---|---|---|
20100172146 | METHOD FOR PRODUCING A HEADLAMP LENS FOR A MOTOR-VEHICLE HEADLAMP - The invention relates to a method for producing a headlamp lens ( | 07-08-2010 |
20100290242 | VEHICLE HEADLIGHT - The invention relates to a vehicle headlamp ( | 11-18-2010 |
20130094237 | Vehicle Headlight - A vehicle headlamp includes a first light source, at least one second light source and an integrally designed, transparent shaped part. The shaped part includes a first optical structure for orienting light radiated by the first light source and at least one second optical structure for orienting light radiated by the second light source. The first optical structure and the second optical structure each have a continuously curved surface or a continuous, curved surface with an extent of at least in each case half a centimetre, in particular one centimetre, in two orthogonal directions. | 04-18-2013 |
20140286032 | VEHICLE HEADLIGHT - The invention relates to a vehicle headlight having at least one light source arrangement comprising a laser, and having a headlight lens comprising a body composed of a transparent material, wherein the body comprises at least one light tunnel and a light-conducting part having at least one optically active light exit surface, wherein the light tunnel comprises at least one, more particularly optically active, light entrance surface and undergoes transition with a bend into the light-conducting part for the purpose of imaging the bend as a bright-dark boundary by means of light coupled or radiated from the light source arrangement into the light entrance surface. | 09-25-2014 |
Jens Fischer, Weilheim DE
Patent application number | Description | Published |
---|---|---|
20120156198 | Antibodies against IL-18R1 and uses thereof - The invention provides anti-IL-18R1 antibodies and methods of using the same. | 06-21-2012 |
20120213774 | Antibodies against human IL33R and uses thereof - An antibody binding to IL33R characterized in that the heavy chain variable domain comprises a CDR3 region of SEQ ID NO:1, a CDR2 region of SEQ ID NO:2 and a CDR1 region of SEQ ID NO:3 and in that the light chain variable domain comprises a CDR3 region of SEQ ID NO:4, a CDR2 region of SEQ ID NO:5 and a CDR1 region of SEQ ID NO:6 or a chimeric, humanized or T cell epitope depleted antibody variant thereof has advantageous properties for the treatment of inflammatory diseases. | 08-23-2012 |
20140315252 | CD40L EXPRESSING MAMMALIAN CELLS AND THEIR USE - Herein is reported a co-cultivation system for co-cultivating a pool of rabbit B-cells or single deposited rabbit B-cells wherein cells CD40L expressing CHO cells are used as feeder in the presence of IL-2 and IL-21. | 10-23-2014 |
Jens Fischer, Darmstadt DE
Patent application number | Description | Published |
---|---|---|
20120196655 | Method for the configuration of a communication device as well as a communication device - Among other things, a method is described for the configuration of a communication device ( | 08-02-2012 |
Jens Fischer, Kiel DE
Patent application number | Description | Published |
---|---|---|
20140116318 | SUBMARINE - A submarine is designed for combating oil when submerged. The submarine includes a snout ( | 05-01-2014 |
Jens Fischer, Weilheim In Oberbayern DE
Patent application number | Description | Published |
---|---|---|
20140044674 | INTERLEUKIN-10 FUSION PROTEINS AND USES THEREOF - The present invention generally relates to fusion proteins of antibodies and interleukin-10 (IL-10). In addition, the present invention relates to polynucleotides encoding such fusion proteins, and vectors and host cells comprising such polynucleotides. The invention further relates to methods for producing the fusion proteins of the invention, and to methods of using them in the treatment of disease. | 02-13-2014 |
20140302015 | ANTIBODIES AGAINST HUMAN IL33R AND USES THEREOF - An antibody binding to IL33R characterized in that the heavy chain variable domain comprises a CDR3 region of SEQ ID NO:1, a CDR2 region of SEQ ID NO:2 and a CDR1 region of SEQ ID NO:3 and in that the light chain variable domain comprises a CDR3 region of SEQ ID NO:4, a CDR2 region of SEQ ID NO:5 and a CDR1 region of SEQ ID NO:6 or a a chimeric, humanized or T cell epitope depleted antibody variant thereof has advantageous properties for the treatment of inflammatory diseases. | 10-09-2014 |
Jens Fischer, Bad Säckingen DE
Patent application number | Description | Published |
---|---|---|
20140214174 | PROCESS FOR PREPARING CERAMIC IMPLANTS FOR MEDICAL PURPOSES - A process for manufacturing a ceramic implant with a surface which forms a permanent bonding to bone cell tissues, the surface providing improved osseointegration, the process comprising the step of:—a pretreatment of the ceramic material with the surface wherein said surface of the ceramic material is exposed to a conditioning plasma, which is produced by means of direct current (DC) or alternating current (AC), such as high or radio frequency (HF, RF), or microwaves (MW) at a low pressure, followed by a second step;—a treatment with a reactive plasma in which an organic compound is added to the plasma for the at least partial application of an organic phase to said surface wherein the organic compound is selected from the group consisting of aliphatic amines, cyclic amines, unsaturated and aromatic amines as well as combinations thereof. | 07-31-2014 |